IUC26569-93

Abstract Code: IUC26569-93   Enfortumab-Vedotin with Pembrolizumab vs platinum-based therapy for advanced urothelial cancer in Oxford. T. Al Kharusi 1, S. San Ti 1, A. Protheroe 1, M. Tuthill 1 (1) Oxford University Hospitals NHS Foundation Trust – United...

IUC26529-89

Abstract Code: IUC26529-89   Sex Differences in Enfortumab Vedotin Efficacy and NECTIN-4 Levels in Metastatic Urothelial Cancer T. Taha 1, A. Alpert 2, A. Rizzo 3, F. Ciccimarra 3, J. Bellmunt 4, S. Gupta 5, R. Kanesvaran 6, Y. Urun 7, M. Santoni 8, I. Waldhorn 2...

IUC25980-89

Abstract Code: IUC25980-89   Impact of Ureteroscopy on Diagnostic Pathways and Radical Nephroureterectomy Outcomes in Upper Tract Urothelial Carcinoma A. Maleki 1, L.F.C. Yu 1, H. Janebdar 1, J. Armitage 1 (1) Addenbrooke’s Hospital, Cambridge –...

IUC25722-83

Abstract Code: IUC25722-83   Bladder Cancer in Young Women: Clinicopathological Features and Risk Factors from a Multi-Center Retrospective Study N. Saberi 1, Y. Ahmad 2, N. Mahmoud Nejad 3, M.H. Izadpanahi 4, A. Behnamfar 1, A. Javid 1, F. Rajaee Rizi 5 (1)...

IUC25665-89

Abstract Code: IUC25665-89   BK Virus Associated Urothelial Carcinoma – A Regional Cohort of Kidney Transplant Recipients N. Beetge 1, L. Ribeiro 2, C. Horsfield 2, R. Zakri 2, J. Olsburgh 2 (1) King’s College London – United Kingdom, (2) Guy’s...

IUC25664-88

Abstract Code: IUC25664-88   Whole-Organ Radiotherapy in the Era of Poor Anatomical Resolution: Evidence from a Population-Based Bladder Cancer Registry (Sri Lanka, 2015–2022) A. Atchuthan 1 (1) National Cancer Institute, Apeksha Hospital, Maharagama, Sri Lanka...
error: Content is protected !!